LHS.CN - Liberty Health Sciences Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
1.02
+0.11 (+12.09%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.91
Open0.91
Bid1.02 x 0
Ask1.03 x 0
Day's Range0.90 - 1.05
52 Week Range0.69 - 2.88
Volume4,254,697
Avg. Volume1,743,180
Market Cap335.492M
Beta4.90
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswireyesterday

    Grit Capital launches GritCAMP Immersive Investment Conference in Muskoka July 25-27th 2018

    Grit Updates the Market on Recent Corporate Initiatives & Milestones. TORONTO, June 22, 2018-- GRIT CAPITAL INC. a capital markets advisory firm known for its aggressive“ out of the box” thinking to capture ...

  • CNW Group16 days ago

    Liberty Health Sciences commends Congressional push to let states follow their own cannabis rules

    TORONTO, June 7, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") applauds Senators Elizabeth Warren and Cory Gardner for introducing a bipartisan bill that would lift the Controlled Substance Act's restrictions on cannabis in states that have written their own laws. "This is a game-changer," said Liberty Health Sciences CEO George Scorsis. "Reputable and responsible medical cannabis companies providing important pain relief and treatment options, deserve the right to conduct business in a transparent matter with a full suite of legal protections in states where cannabis is legal.

  • CNW Group23 days ago

    Liberty Health Sciences opens Port St. Lucie's first medical cannabis dispensary

    TORONTO, May 31, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") today announced the opening of its Cannabis Education Center ("CEC") in Port St. Lucie, Florida. This is Liberty's fourth CEC to open in the state this year and advances the Company's mission to provide Florida's residents with convenient access to high-quality medical cannabis and patient-focused educational resources.

  • CNW Group24 days ago

    Liberty Health Sciences to be exclusive distributor of Isodiol International products throughout Florida and Massachusetts

    TORONTO, May 30, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") is pleased to announce that it has signed a licensing agreement with Isodiol International Inc. ("Isodiol"), a leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of CBD consumer products, to provide a complementary suite of medical cannabis products to patients in Florida and Massachusetts. "Liberty is proud to team up with Isodiol, a company renowned for its ability to process and extract high purity CBD on an industrial scale," said George Scorsis, Director and CEO of Liberty.

  • CNW Group29 days ago

    Liberty Health Sciences Signs Exclusive Agreement to Bring Award-Winning Mary's Medicinals Cannabis Products to Massachusetts

    TORONTO, May 25, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") today announced the expansion of the Company's partnership with Colorado-based MM Technology Holdings, LLC ("Mary's") to be the exclusive provider of the award-winning line of Mary's Medicinals® cannabis products in Massachusetts. Under the agreement, Liberty will produce and distribute Mary's suite of innovative cannabis products, featuring a variety of novel delivery methods, under license in Massachusetts for both medical and recreational users, when permitted.

  • CNW Grouplast month

    Liberty Health Sciences Teams Up with Solomon Wilcots for AAMPA's Conference on the NFL and Medical Cannabis

    TORONTO, May 18, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") today announced it has teamed up with Emmy Award-winning NFL broadcaster and retired player Solomon Wilcots.  Mr. Wilcots is speaking this afternoon in Miami at the American Medical Marijuana Physicians Association's ("AAMPA") conference on "The NFL and Medical Cannabis". "Education is critical to helping doctors and the patients they treat understand and benefit from medical cannabis," said George Scorsis, Director and CEO of Liberty.

  • CNW Grouplast month

    Liberty Health Sciences Continues Rollout of its Cannabis Education Centers with new Location in Tampa, Florida

    TORONTO, May 18, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") today announced the successful opening of its Cannabis Education Center ("CEC") in Tampa, Florida. The Tampa location becomes the third CEC to open in the state as part of the Company's strategy to roll its unique patient-centric dispensaries across Florida.

  • Liberty Health Sciences names Stephanie Kubacki as Vice President of Marketing
    CNW Grouplast month

    Liberty Health Sciences names Stephanie Kubacki as Vice President of Marketing

    TORONTO, May 15, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") has named seasoned marketing executive Stephanie Kubacki as Vice President of Marketing, effective June 1, 2018. Ms. Kubacki comes to Liberty with and exceptional track record managing and building high-profile brands in the highly regulated beverage industry. "I am incredibly excited to welcome Stephanie to the leadership team where she will play an important role in pursuing our aggressive growth strategy" said George Scorsis, Director and CEO of Liberty.

  • CNW Grouplast month

    Liberty Health Sciences to Bring Solei Cannabis Brand to Florida and Massachusetts

    TORONTO, May 11, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") today announced it has signed an amended licensing agreement with Aphria Inc. ("Aphria") to add Solei Sungrown Cannabis ("Solei"), to the Company's growing portfolio of brands. Under the terms of the agreement, Liberty will be able to produce and sell Solei in Florida and Massachusetts, subject to receipt of all required approvals from the Florida Department of Health, Office of Medical Marijuana Use, and from the Commonwealth of Massachusetts, Medical Use of Marijuana Program or the Massachusetts Cannabis Control Commission, if any.

  • CNW Grouplast month

    Liberty Health Sciences Strengthens Presence in Florida with St. Petersburg Cannabis Education Center

    TORONTO, May 10, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") today announced the successful opening of its second Florida Cannabis Education Center ("CEC") with a grand opening ceremony set for May 17, 2018 at 5:30 pm EST. The St. Petersburg location is strategically located within a five-mile radius of 90 percent of the city's 257,000 residents. "Liberty Health Sciences is proud to be part of the St. Petersburg community and to fulfill our promise to provide the area with our patient-centric approach to cannabis through unparalleled service and educational resources," said George Scorsis, Director and CEO of Liberty.

  • GlobeNewswirelast month

    Liberty Health Sciences Announces Closing of Bought Deal Financing

    Liberty Health Sciences Inc. (CSE:LHS) (LHSIF) (“Liberty” or the “Company”) is pleased to announce it has closed its short form prospectus offering, on a bought deal basis, including the exercise in full of the underwriters' over-allotment option. A total of 25,555,875 units (the “Units”) of the Company were sold at a price of $0.90 per Unit, for aggregate gross proceeds of $23,000,287.50 (the "Offering"). Each Warrant will entitle the holder thereof to purchase one common share of the Company (a “Warrant Share”) at a price of $1.10 until May 10, 2020.

  • CNW Group2 months ago

    Liberty Health Sciences continues to expand distribution capabilities

    TORONTO, April 13, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") announced today the Company will open its second medical cannabis dispensary in Florida, strategically located in St. Petersburg, a city with a population of 257,083. Pending approval by The Florida Department of Health ("DOH"), the opening is scheduled for April 17. "The opening of our second Florida dispensary demonstrates our ongoing commitment to expand our footprint in the state, making it more convenient for Floridians to access high quality medical cannabis," said CEO George Scorsis.

  • CNW Group2 months ago

    Liberty Health Sciences' sales surge on explosive market growth in early 2018

    TORONTO, April 11, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") today announced that the Company has recorded a 253% increase in monthly revenue since the start of 2018, and a 100% increase in its served patient count. The surge has been fueled by unprecedented growth in the number of registered medical cannabis patients and physicians in the state of Florida.

  • PR Newswire3 months ago

    Liberty Health Sciences Expands National Footprint with Controlling Interest in Massachusetts-based Cultivation and Dispensary Operation

    Liberty agrees to acquire 75% ownership of William Noyes Webster Foundation Inc. TORONTO, March 27, 2018 /PRNewswire/ - Liberty Health Sciences Inc. (CSE: LHS or US OTCQX: LHSIF) (the "Company" or "Liberty") is pleased to announce it has agreed to acquire a 75% ownership interest (the "Transaction") in Massachusetts-based William Noyes Webster Foundation, Inc., ("WNWF" or "the Foundation") for US$16 million, pursuant to a binding term sheet. WNWF owns an integrated medical cannabis license in the Commonwealth of Massachusetts and has a cultivation facility and a dispensary location both nearing completion, as well as leases and local governmental approvals in place for two additional dispensary locations.

  • CNW Group3 months ago

    Liberty Health Sciences Expands National Footprint with Controlling Interest in Massachusetts-based Cultivation and Dispensary Operation

    Liberty agrees to acquire 75% ownership of William Noyes Webster Foundation Inc. TORONTO, March 27, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS or US OTCQX: LHSIF) (the "Company" or "Liberty") is pleased to announce it has agreed to acquire a 75% ownership interest (the "Transaction") in Massachusetts-based William Noyes Webster Foundation, Inc., ("WNWF" or "the Foundation") for US$16 million, pursuant to a binding term sheet. WNWF owns an integrated medical cannabis license in the Commonwealth of Massachusetts and has a cultivation facility and a dispensary location both nearing completion, as well as leases and local governmental approvals in place for two additional dispensary locations.

  • CNW Group3 months ago

    Liberty Health Sciences Applauds Protections Provided by Congress for State-Approved Medical Cannabis Laws

    TORONTO, March 23, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS or US OTCBB: LHSIF) (the "Company" or "Liberty") applauds today's passage of the 2018 omnibus appropriations package, which includes the Rohrabacher-Leahy Amendment ("Rohrabacher-Leahy") restricting the Department of Justice ("DOJ") from interfering with the rights of patients and medical cannabis companies such as Liberty operating in compliance with State laws. As a result, the DOJ will not be able to pursue enforcement actions against legal medical cannabis cultivators, distributors and licensees operating in compliance with State laws, thereby protecting Liberty's business, operations and patients.

  • PR Newswire3 months ago

    Liberty Health Sciences Applauds Protections Provided by Congress for State-Approved Medical Cannabis Laws

    TORONTO, March 23, 2018 /PRNewswire/ - Liberty Health Sciences Inc. (CSE: LHS or US OTCBB: LHSIF) (the "Company" or "Liberty") applauds today's passage of the 2018 omnibus appropriations package, which includes the Rohrabacher-Leahy Amendment ("Rohrabacher-Leahy") restricting the Department of Justice ("DOJ") from interfering with the rights of patients and medical cannabis companies such as Liberty operating in compliance with State laws. As a result, the DOJ will not be able to pursue enforcement actions against legal medical cannabis cultivators, distributors and licensees operating in compliance with State laws, thereby protecting Liberty's business, operations and patients.

  • PR Newswire3 months ago

    Liberty Health Sciences Appoints Jennifer Timothee Oliveras, M.D., as Medical Director

    TORONTO, March 21, 2018 /PRNewswire/ - Liberty Health Sciences Inc. (CSE: LHS or US OTCBB: LHSIF) (the "Company" or "Liberty") is pleased to announce that Jennifer Timothee Oliveras, M.D.  will be joining the Company as Medical Director, overseeing Liberty's patient-focused approach to selling medical cannabis. Dr. Timothee brings considerable expertise and she shares the Company's commitment to educating the public on the medical benefits of cannabis.

  • CNW Group3 months ago

    Liberty Health Sciences Appoints Jennifer Timothee Oliveras, M.D., as Medical Director

    TORONTO, March 21, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS or US OTCBB: LHSIF) (the "Company" or "Liberty") is pleased to announce that Jennifer Timothee Oliveras, M.D.  will be joining the Company as Medical Director, overseeing Liberty's patient-focused approach to selling medical cannabis. Dr. Timothee brings considerable expertise and she shares the Company's commitment to educating the public on the medical benefits of cannabis.